C. Ciancioni

In vivo induction of interleukin-1 during hemodialysis.

J. Cavaillon, M. Kazatchkine, N. Haeffner‐Cavaillon, 1989, Kidney international.

CARNITINE IMPROVES LIPID ANOMALIES IN HAEMODIALYSIS PATIENTS

B. Lacour, J. Chanard, T. Drüeke, 1980, The Lancet.

Comparison of ketoacids and low protein diet on advanced chronic renal failure progression.

P. Jungers, P. Chauveau, N. Man, 1987, Kidney international. Supplement.

Dialysis-associated adverse reactions with high-flux membranes and microbial contamination of liquid bicarbonate concentrate.

N. Man, J. Faivre, C. Ciancioni, 1988, Contributions to nephrology.

48-hour kidney preservation (initial perfusion with potassium and magnesium-rich solution).

M. Lacombe, C. Ciancioni, H. Kreis, 1972, Revue europeenne d'etudes cliniques et biologiques. European journal of clinical and biological research.

Prevention of hepatitis B in hemodialysis patients using hepatitis B immunoglobulin. A controlled study.

J. Fermanian, D. Kleinknecht, A. Couroucé, 1977, Clinical nephrology.

Plasma aluminum and iron kinetics in hemodialyzed patients after i.v. infusion of desferrioxamine.

N. Man, P. Allain, Y. Mauras, 1984, Transactions - American Society for Artificial Internal Organs.

Concomitant removal of aluminium and iron by haemodialysis and haemofiltration after desferrioxamine intravenous infusion.

N. Man, P. Allain, Y. Mauras, 1985, Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress.

Blood access in haemodialysis: long term results.

J. Zingraff, P. Bonnaud, J. Crosnier, 1977, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association.

SEVERE HYPOGLYCÆMIA DUE TO BETA-BLOCKING DRUGS IN HÆMODIALYSIS PATIENTS

K. Samii, J. Rottembourg, C. Ciancioni, 1976, The Lancet.